A Global Presence in Pharmaceutical Manufacturing
Since 1950, Taro has developed, manufactured, and marketed high-quality branded and generic pharmaceutical products. Today, our employees in the U.S., Israel, Canada, Ireland and the U.K., are proud to meet the needs of patients and healthcare professionals in these and other countries.
Taro's prescription and over-the-counter medications are used primarily in dermatology, pediatrics, cardiology and neurology. In all, we produce more than 180 pharmaceutical products, including topical preparations (creams, ointments, gels, solutions), oral medications (tablets, capsules, powders, liquids) and sterile products (injectables, ophthalmic drops, powders).
Success Based on Research
Taro's success reflects a commitment we made in the early 1990s to grow through research and development. Since then, we have invested 12-16% of gross sales in research each year, for a total of more than $190 million. Today, approximately one in five Taro employees work in R&D, led by more than 70 M.D. and Ph.D. scientists. Taro has more than 100 ANDA drug approvals in the U.S. alone.
Excellent Record of Quality
Our research has yielded another major benefit for Taro: it has enabled us to develop the active pharmaceutical ingredients (API's) for many of our key products. By manufacturing our own API's, Taro is able to control the quality and availability of these critical chemicals. But API production is only one part of Taro's quality story. Our manufacturing facilities in Israel and Canada have earned high marks from regulators in those countries and elsewhere.
- Core Sales Territory:
Global Regulated Markets
- Formed: 1950